학술논문
Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD)
Document Type
Article
Author
Source
In: International Journal of Gynecological Cancer . (International Journal of Gynecological Cancer, 1 July 2022, 32(7):939-943)
Subject
Language
English
ISSN
15251438
1048891X
1048891X